Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 63 days ( -5.01 % )
Last Price $0.86 0 %
High/ Low $0.86 - $0.86 0%
Chg 7 Days N/A $0.86 $0.86
Chg 30 Days N/A $0.86 $0.86
Chg 12 mos 19.44 % $0.720 $0.86
Trend - 3 mos 5.93 % Width: 13.47 %
Trend - 12 mos -7.78 % Width: 196.15 %
Pred. range - 3 mos $0.83 - $0.94 -3.32 % - 9.70 %
Pred. range - 12 mos $0.390 - $1.16 -54.61 % - 34.42 %
Short MA avg 3 mos Buy 2024-01-04 - 59 days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2024-01-02 - 61 days
Long MA avg 12 mos Buy 2023-12-14 - 72 days
Short/Long MA avg 12 mos Buy 2023-12-19 - 69 days
Pivot Short Sell 2024-03-27 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT